Class summary at a glance.

Every drug in the Opioid Analgesic class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $163.2Mcombined across class
Total Rx claims: 19.7M6.7M unique beneficiaries
Generic mfrs (active): 12across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Tramadol

Brand: ConZip · 19.7M Part D claims (CY24) · 6.7M beneficiaries · First FDA approval: 2002-06-19

12 generic mfrs 187 plans require PA

Low NADAC$0.024

→

Avg plan cost$0.824

Part D spend $163.2M 34× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.